Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals Revenue

Amneal Pharmaceuticals had revenue of $701.78M in the quarter ending June 30, 2024, with 17.15% growth. This brings the company's revenue in the last twelve months to $2.60B, up 12.37% year-over-year. In the year 2023, Amneal Pharmaceuticals had annual revenue of $2.39B with 8.20% growth.

• Revenue (ttm): $2.60B
• Revenue Growth: +12.37%
• P/S Ratio: 0.82
• Revenue / Employee: $330,954
• Employees: 7,850
• Market Cap: 2.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.39B	181.30M	8.20%
Dec 31, 2022	2.21B	118.64M	5.67%
Dec 31, 2021	2.09B	101.15M	5.08%
Dec 31, 2020	1.99B	366.15M	22.51%
Dec 31, 2019	1.63B	-36.62M	-2.20%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.